Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2013 / Oct / Cataract Surgery Prolongs Life
Anterior Segment Cataract

Cataract Surgery Prolongs Life

The benefits of cataract surgery extend well beyond improvement in visual acuity, according to results from a recently-published study by Australian researchers

By Mark Hillen 10/28/2013 1 min read

Share

0213-202-fig1

“Cataract surgery makes my patients’ lives better,” says Phillipe Crozafon, an ophthalmologist based in Nice, France. “They are depressed when they can’t even see the television. I know the difference that the surgery makes; I’ve seen it in my patients. They are reborn. I can confirm. I had my cataract removed, and my life was different – far better.”

Visual impairment has long been known to rob people of their quality of life, and condemn them to increased morbidity and a shorter life. Now, Calvin Sze-un Fong and colleagues at Sydney University’s Department of Ophthalmology have demonstrated the full impact of cataract surgery: significantly increased long-term survival (1). They studied 354 patents from the Blue Mountains region around Sydney who were aged 49 years or older and who had both cataract and visual impairment (or had undergone cataract surgery before baseline examinations). Presenting visual impairment (PVI) was defined as visual acuity less than 39 letters (less than 20/40) in the better eye, with or without the habitual use of distance glasses (if worn). Patients with AMD were excluded. Best-corrected VI (BCVI) was defined as the same level of visual acuity after subjective refraction. Mean follow-up of patients was 13.2 years at study completion.

The 15-year crude mortality rates of those who had and had not undergone cataract surgery were similar, but differences in many of the baseline demographic factors skewed these results. Adjustment for age and gender differences revealed that cataract surgery significantly improved survival. The additional correction of other baseline factors, including cardiovascular disease, in the multivariate analysis, showed that cataract surgery improved survival by approximately 60 percent – irrespective of whether mortality risks were assessed by PVI or BCVI measures (see Figure 1). Impaired vision may increase mortality among the elderly for a number of reasons, not least of which is the fact that most elderly patients receive a multitude of medications. Ensuring patient adherence to dosing regimens is challenging enough – especially with polypharmacy – but this becomes far harder with poor eyesight (2). This study shows that by removing cataracts, ophthalmologists not only increase a patient’s quality of life, but also extend their life.

References

  1. C. S. Fong, P. Mitchell, E. Rochtchina, et al., “Correction of Visual Impairment by Cataract Surgery and Improved Survival in Older Persons: The Blue Mountains Eye Study Cohort”, Ophthalmology, 120, 1720–7 (2013). A. J. Claxton, J. Cramer and C. Pierce, “A systematic review of the associations between dose regimens and medication compliance”, Clin Ther, 23, 1296–1310 (2001).

About the Author(s)

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

More Articles by Mark Hillen

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: